e-Profile Login and ID Quick Search
Stakeholders Share Information About Fighting Internet Drug Outlets at Senate Committee Hearing
Stakeholders representing varied consumer organizations had the opportunity to present testimony to the Senate Committee on the Judiciary about the problem of counterfeit goods sold via the Internet, including information about efforts to fight rogue Internet drug outlets on February 16, 2011. At the hearing titled, "Targeting Websites Dedicated To Stealing American Intellectual Property," Senator Chuck Grassley reminded participants that piracy and counterfeiting, activities often promoted via Internet Web sites, can present serious health and safety problems, including the threat from counterfeit pharmaceuticals. Christine N. Jones, executive vice-president, general counsel, and corporate secretary of The Go Daddy Group, Inc presented information about the company’s efforts to work with law enforcement to shut down domain names associated with the marketing of counterfeit goods, including rogue Internet drug sites. The company’s testimony (PDF) indicated that in 2010 alone Go Daddy worked with Food and Drug Administration (FDA) and the United States Drug Enforcement Administration “to investigate and take down over 36,000 such websites.” Denise Yee, of Visa Inc noted in her testimony that Visa Inc “has joined the Center for Safe Internet Pharmacies (CSIP) to combat illegal distribution and counterfeit pharmaceuticals online.”
On December 14, 2010, at a meeting coordinated by the US Office of the Intellectual Property Enforcement Coordinator, NABP participated in the panel discussion, “Dangers of Counterfeit Pharmaceuticals” and was joined by security and legal experts. More information about NABP’s participation is available in the January 2011 NABP Newsletter article “NABP Joins Other Stakeholders at White House to Discuss Fighting Rogue Internet Drug Sites and Counterfeit Drugs.”
